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Abstract
Background: A lot of studies were directed to explore the relation between drug abuse and
neuropsychological functions. Some studies reported that even after a long duration of
disappearance of withdrawal or intoxication symptoms, many patients have obvious deterioration
of cognitive functions. The aim of this study was to explore the relationship between the substance
use disorders and the executive functions.
Methods: Two groups were selected for this study. An experimental group consisted of 154
patients and further subdivided according to the substance used into three different subgroups:
opioid, amphetamine and alcohol groups which included 49, 56 and 49 patients respectively. The
control group was selected matching the experimental group in the demographic characteristics
and included 100 healthy persons. Tools used were: Benton visual retention tests, color trail
making test, Stroop colors-word test, symbol digit modalities test, the five dots cognitive flexibility
test, and TAM verbal flexibility test. All the data were subjected to statistical analysis
Results: The study showed that the group of drug-dependent subjects performed significantly
worse than the comparison group on all measures Also, there were significant differences among
the subgroups as the alcoholic group was much worse followed by the amphetamine then the
opioids groups. Patients with longer duration of dependence and multiple hospital readmissions
were much worse in comparison to patients with shorter duration of dependence and less
readmission.
Conclusion: The study confirmed that the functions of specific brain regions underlying cognitive
control are significantly impaired in patients of drug addiction. This impairment was significantly
related to type of substance, duration of use and number of hospitalization and may contribute to
most of behavioral disturbances found in addicts and need much attention during tailoring of
treatment programs.
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Background
A lot of studies were directed to explore the relation
between drug abuse and neuropsychological functions.
The interest in studying this relationship is the result of
the scientific achievements in the field of neuropsychol-
ogy. Cognitive deficits associated with the chronic abuse
of drugs have important theoretical and clinical signifi-
cance. Such deficits reflect changes to the underlying cor-
tical, sub-cortical and neuromodulatory mechanisms that
underpin cognition, and also interfere directly with reha-
bilitative programs [1,2]. Alcohol induced cognitive defi-
cits include impaired decision-making, response
inhibition, planning and working memory [3]. Heroin
addicts tended to perform worse than controls particularly
on various dimensions of impulsivity, attention, learning,
working memory and pattern recognition, all primarily
prefrontal functions [4]. Chronic use of amphetamine has
been associated with a wide range of cognitive deficits,
involving domains of attention, inhibitory control, plan-
ning, decision-making, learning and memory [5]. Despite
the growing evidence of the negative impacts of different
substances of abuse on the brain, neuropsychological
research directly comparing cognitive performance in dif-
ferent phases of addiction illness and different substances
are still sparse with controversial results.
Aim of the work
This work was done to test the hypothesis of cognitive dys-
functions associated with chronic use of psychoactive sub-
stances in a sample of patients in Saudia Arabia. The study
was done to explore the relationship between the sub-
stance use disorders and the executive functions and to
answer certain important study questions: 1) Are there sig-
nificant differences between the addicts and healthy peo-
ple regarding neuropsychological functions? 2) Are there
significant differences between users of different sub-
stances regarding these neuropsychological functions? 3)
Does the duration of abuse lead to significant differences
among addicts in the performance of neuropsychological
tasks? 4) Does the frequency of hospitalization lead to sig-
nificant differences among addicts in the performance of
neuropsychological tasks?
Methods
The current study had a cross sectional design. It was done
in Al-Amal complex for mental health which is located in
Dammam. The complex is affiliated to the ministry of
health of the kingdom of Saudia Arabia (KSA). The pro-
posal of the study was approved by both of the scientific
and ethical committee of the complex prior to data collec-
tion. Subjects: To answer the first study question, two
groups of subjects were selected, an experimental group
consisted of 154 patients and control group consisted of
100 healthy persons. The control group was selected
matching the experimental group in the demographic
characteristics (age, education level and marital state). To
answer the second study question, the patients were fur-
ther subdivided according to the substance used into three
different groups: alcohol, heroin and amphetamine
groups which included 49, 49 and 56 patients respec-
tively. The three groups did not differ statistically in age or
level of education. These substances were selected because
of their popularity in the region and known chronicity. To
answer the third study question the patients were also
divided into 4 subgroups according to duration of sub-
stance use, from 1-5 years, 6-10 years, 11-15 year and >15
years. Lastly, to answer the fourth study question, patients
were classified according to the frequency of hospital
admission into 4 categories; once, twice, thrice, and ≥ 4
admissions. The patient group was selected from in-
patients few days after finishing their detoxification pro-
gram and according to random list prepared by randomi-
zation computer program. Due to limited number of
female patients all subjects were males. The exclusion cri-
teria used in this study included any significant use of
other substances within past two years and significant his-
tory of physical or mental disorders that could impact cog-
nitive functions (eg. mood and anxiety disorders, major
organ failure, etc). All subjects were free of withdrawal
symptoms and free of drugs at the time of testing. Caffein-
ated beverages and nicotine were not allowed during the
time of testing. Procedures of the study: 1) Oral
informed consent was taken from all subjects 2) Psychiat-
ric assessment including details of substance use and treat-
ment, duration of use and number of hospitalizations. 3)
Patients were assessed using mini international neuropsy-
chiatric interview (MINI) [6]. 4) Urine test for different
substances of abuse was done for all subjects to confirm
the type of substance and exclude other substances 5)
Neuropsychological battery to assess cognitive functions.
Tools applied: 1) MINI which is a short structured diag-
nostic interview for DSM-IV and ICD-10 psychiatric disor-
ders. The scale was translated to Arabic and validated
previously [6] The MINI-Plus was selected over other
screening instruments because of its ease of administra-
tion. 2) Neuropsychological battery which was formed
from Benton visual retention test, color trail making test
(CTMT), Stroop colors-word test, symbol digit modalities
test (SDMT), the five dots cognitive flexibility test, TAM
verbal flexibility test. All previous tools were translated
into Arabic prior to application.
The color trail making test uses numbered colored circles
and universal sign language symbols. The circles are
printed with vivid pink or yellow backgrounds that are
perceptible to colorblind individuals. The test has two
forms of application. In the first form, the subject uses a
pencil to rapidly connect circles numbered 1 through 25
in sequence. In the second application, the subject rapidly
connects numbered circles in sequence, but alternatesBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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between pink and yellow colors. It means that the com-
plexity increased in the second form as there are possibil-
ities of both number and color errors. This test is a
measure of some of the frontal lobe functions especially
cognitive flexibility, perceptual tracking, sequencing of
events, sustained and divided attention and graphomotor
skills [7].
The Stroop color word task [8] is a test of selective atten-
tion and cognitive flexibility. The task takes advantage of
our ability to read words more quickly and automatically
than we can name colors. If a word is printed or displayed
in a color different from the color it actually names we will
read the word more readily than we can name the color in
which it is displayed. The cognitive mechanism involved
in this task is called selective or directed attention, as the
subject has to manage his attention, resist interference
from irrelevant stimuli, inhibit or stop one response in
order to say or do something else. The investigators used
the test in 5 forms gradually increasing in complexity. In
the first form, the subject was asked to recognize colors. In
the second form, the subject was asked to read the words
written in black (names of colors). In the third form, the
subject was asked to read the names of the colors printed
in different colors. In the fourth form, the subject was
asked to recognize the color of the printed words (names
of colors). In the last form, the subject was asked to seri-
ally read the words in one row and recognize the color in
one row. The time needed to each application and
number of errors was recorded on a special form.
The symbol digit modalities test (SDMT) [9] involves a
simple substitution task that normal children and adults
can easily perform. Using a reference key, the examinee
has 90 seconds to pair specific numbers with given geo-
metric figures. This test is a measure of speed of mental
processing, attention and concentration, divided atten-
tion, ability to fix and detect errors and learn from them.
The scoring ranges from 0-110, with higher scores repre-
senting better performance.
The five dots test assesses figural fluency and cognitive
flexibility. Figural fluency is considered one of the execu-
tive functions of the right frontal lobe. Patients are
instructed to connect standardized 5 points to do the larg-
est number of different designs within 5 minutes [10].
TAM verbal flexibility is a test of word fluency that consid-
ered an executive function for the left frontal lobe. It is
considered an Arabic analogue of FAS controlled oral
word association test [8,11].
The Benton revised visual retention test [12] is a widely
used instrument that assesses visual-motor coordination,
visual perception, visual memory, and attention and vis-
uoconstructive abilities. It was translated to Arabic and
validated previously [13]. In this study the investigators
used the test in three forms, in the first form each subject
was asked to copy a shape while seeing it. In the second
form each subject was asked to copy a shape from the
memory immediately after seeing it for 5 seconds and in
the last form each subject was asked to copy a shape from
the memory 10 seconds after removal of the shape.
Statistical Analysis
All the data was subjected to statistical analysis using SPSS
version 10.0. Tests for comparisons used included the
mean and standard deviation and multivariate analysis of
co-variance (MANCOVA). Level of significance was
detected at p value 0.05.
Results
Patient control comparisons
The mean age of patient group was 33.16 ± 8.3 years and
the mean age for the control group was 31.24 ± 9.4 with
no statistical significant differences between. All the age
ranges and education are showed in Table 1.
As shown in Table 2, in color trail making test (CTMT),
there were statistically significant differences between
patients and control groups as the time needed by patient
Table 1: Age and level of education of patient and control groups
Number of patients according to years of education Mean age
Group ≤ 6 years 7-9 years 10-12 years > 12 years Age range ± SD
Alcohol 7 16 22 5 19-54 30.22 ± 8.35
Heroin 7 15 23 5 21-51 32.51 ± 9.22
Amphetamine 8 14 28 4 18-49 33.34 ± 7.14
All patients 22 45 73 14 18-54 33.16 ± 8.3
Control 14 29 49 8 18-50 31.24 ± 9.4Behavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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group was more in form 1 and 2. Also, the patient group
had more color sequence errors in the first form and more
color and number sequence errors in the second form.
In Stroop task, there was no significant difference in
form 1 while in form 2 and 3 there were statistically sig-
nificant differences only in time needed and p value was
0.05 (see Table 3). Also in Stroop form 4 and 5, there were
statistically significant differences as regard to time
needed and number errors.
As shown in Table 4, the results of five dots test denoted
that the total score of the test was better with control
group than with patient group while the patient group
revealed more repetitions and less number of unique
designs.
Also the total score of TAM verbal flexibility test was better
with control group than patient group as they succeeded
in naming of larger numbers of words with less repetition
and interference than patient group. The scores of symbol
digit modalities test (SDMT) were higher for the control
group denoting better functions.
On the Benton visual retention test, control subjects
scored significantly better and had significantly fewer
errors than did drug-dependent patients (see Table 5).
Differences between patients according to type of 
substance
As shown in Table 6, the alcoholic group took longer time
than the heroin and amphetamine groups to achieve the
responses in the first form of color trail making test
(CTMT)  while in the second form the worst was the
amphetamine group followed by alcohol and the best was
the heroin group. In the second form of the test, the
number of errors with alcoholic group was significantly
higher than with heroin and lastly amphetamine groups.
In Stroop test, there were statistically significant differ-
ences between the three groups of patients as the time
needed in all forms of the test was significantly more with
alcoholic groups followed by amphetamine group and
lastly the heroin group. Also, the number of errors was
more with the alcoholic group in form number 1 and 2
while it was more with amphetamine group in form
number 5. In five dots test, there were statistically signif-
icant differences between the three patients groups as the
total score of the test and the ability to produce unique
designs were better with heroin group followed by alcohol
and lastly the amphetamine.
In TAM verbal flexibility test and symbol digit modali-
ties test (SDMT), there were statistically significant differ-
ences between groups as the scores were more in the
heroin group in all aspects of the test followed by the
other two groups. Lastly in Benton test, there were no sta-
tistically significant differences between the different sub-
groups of patients in all forms of the test.
Differences between patients according to duration of use
As shown from Table 7, in color trail making test (CTMT),
Stroop test, five dots test and symbol digit modalities test
(SDMT), there were statistically significant differences
between the different durations as the group of the least
duration (1-5 years) was relatively the best group in per-
formance and the group of the longest duration(> 15
years) was the worst. The same was also noticed as regard
rotation errors in Benton which increased significantly
with the duration of use. However, there were no statisti-
cally significant differences between the groups in TAM
verbal flexibility test and other aspects of Benton test. The
number of color errors in color trail making test (CTMT)
was more with the group of the shortest duration.
Differences between patients according to number of 
hospitalizations
In all tests applied, the scores were better in the group
admitted once and worst in the group of ≥ 4 admissions
Table 2: Results of the color trail making test (CTMT)
CTMT Item Patients
mean ± SD
Control
mean ± SD
F value P value
Form 1 Time 74.72 ± 1.95 68.26 ± 2.14 F(1,15) = 4.52 0.05
Color errors 0.71 ± 0.08 0.28 ± 0.09 F(2,16) = 10.92 0.001
Form 2 Time 118.36 ± 3.01 105.60 ± 3.30 F(1,40) = 7.37 0.01
Number errors 0.47 ± 0.08 0.17 ± 0.09 F(2,20) = 5.95 0.01
Color errors 0.75 ± 0.09 0.33 ± 0.10 F(3,21) = 8.03 0.005
CTMT: color trail making test.
Higher scores indicate poorer functionBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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(see Table 8 and 9). In the first application of Benton
(Table 9), the total number of errors, the distortion errors
and the rotation errors were less in the group of least
admission and increased gradually with increase of
admissions and p value ranged from 0.05 to 0.01. In the
second application the number of correct answers
decreased significantly with the increase in number of
admissions and p value persisted at the same level 0.01.
While in the third application, the number of errors, the
number of correct answers and the distortions were signif-
icantly worse with the group of ≥ 4 admissions.
Discussion
Several authors have stressed the presence of cognitive
deficits in patients with substance use disorders however
most of studies focused on alcohol [14-16]. The current
study tried to test the hypothesis of cognitive dysfunctions
associated with three common substances of abuse in Sau-
dia Arabia and tried to find the effect of different sub-
stances and the relation of cognitive deficits to duration of
use and number of hospitalizations. It described an
assessment of neuropsychological functions in newly
abstinent drug dependent subjects and in healthy non-
drug using controls. The results showed that the group of
drug-dependent subjects performed significantly worse
than the comparison group on all measures. The differ-
ences increased much with the increase in the complexi-
ties of the tasks. Additionally, significant differences in
neuropsychological function were identified in groups
based on primary drug of abuse. Also, the study reported
significant differences in neuropsychological functions in
groups based on duration of addiction and number of
hospitalizations, with subjects who report a shorter dura-
tion of addiction and less frequent hospitalization gener-
ally out-performing subjects with longer periods of
addiction and more frequent hospitalization. All these
findings confirmed the presence of impairment in the
functions of frontal and temporal lobes which considered
responsible for the cognitive flexibility and may be one of
the reasons behind failure of some patients to change
their life style.
Impaired color trail making test (CTMT) reflects distur-
bance of cognitive flexibility, perceptual tracking,
sequencing of events, sustained and divided attention and
graphomotor skills. This test denoted disturbed functions
of lateral temporal lobe which is the brain area responsi-
Table 3: Results of Stroop colors-word test
Stroop Patients
Mean ± SD
Control
Mean ± SD
F value P value
Time 2 17.92 ± 0.49 16.49 ± 0.54 F(1,331) = 3.87 0.05
Time 3 13.63 ± 0.26 12.77 ± 0.29 F(1,16) = 4.50 0.05
Time 4 26.53 ± 0.68 25.00 ± 0.75 F(1,98) = 3.92 0.05
Time 5 30.15 ± 0.69 26.18 ± 0.76 F(1,22) = 13.45 0.001
Errors 4 2.70 ± 0.16 1.50 ± 0.18 F(1,9) = 22.46 0.001
Errors 5 2.63 ± 0.21 2.19 ± 0.23 F(1,110) = 3.89 0.05
Higher scores indicate poorer function
Table 4: Results of five dots, TAM verbal flexibility and symbol digit modalities tests (SDMT)
Test Items Patients
mean ± SD
Control
mean ± SD
F value P value
Five dots test Total scorea 27.92 ± 0.63 33.81 ± 0.69 F(1,6) = 35.87 0.001
Unique designsa 24.63 ± 0.60 31.50 ± 0.66 F(1,4) = 54.27 0.001
Repetitions b 3.38 ± 0.28 2.58 ± 0.31 F(1,161) = 3.90 0.05
TAM test Words a 34.69 ± 1.25 45.25 ± 1.38 F(1,7) = 29.11 0.001
Interference a 1.02 ± 0.15 0.25 ± 0.16 F(1,110) = 11.04 0.001
Repetitions b 0.69 ± 0.09 0.18 ± 0.10 F(1,35) = 12.90 0.001
Total score a 41.90 ± 1.18 51.79 ± 1.29 F(1,7) = 29.04 0.001
SDMT a 30.10 ± 1.43 54.42 ± 1.58 F(1,110) = 117.13 0.000
a. Higher scores indicate better function.
b. higher scores indicate poorer function
TAM: TAM verbal flexibility test.
SDMT: Symbol digit modality testBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
Page 6 of 11
(page number not for citation purposes)
Table 5: Results of Benton visual retention test
Benton Item Patients mean ± SD Control mean ± SD F value P value
Form 1 Correct Responses a 5.76 ± 0.18 6.43 ± 0.20 F(1,7) = 5.68 0.05
Errors b 5.32 ± 0.2 4.45 ± 0.27 F(2,43) = 5.15 0.01
Form 2 Correct responses a 6.30 ± 0.19 6.90 ± 0.21 F(1,50) = 4.03 0.05
Errors b 3.92 ± 0.21 3.23 ± 0.23 F(1,14) = 4.60 0.05
Form 3 Correct responses a 6.56 ± 0.17 7.10 ± 0.18 F(1,30) = 4.17 0.05
Errors b 3.42 ± 0.18 2.79 ± 0.20 F(2,44) = 5.12 0.01
a. Higher scores indicate better function.
b. higher scores indicate poorer function
Table 6: Differences between patients according to type of substance
Test items Alcohol
mean ± SD
Heroin
mean ± SD
Amphetamine
mean ± SD
F value P value
CTMT Time 1 b 85.69 ± 34.14 75.3 ± 22.09 69.47 ± 18.61 F(2,101) = 5.3 0.006
CTMT Time 2 b 120.37 ± 41 111.34 ± 33.42 132.62 ± 5.02 F(2,101) = 5.02 0.008
CTMT errors 2 b 0.59 ± 1.25 0.27 ± 0.84 0.19 ± 1.33 F(2,62) = 3.18 0.048
Stroop Time 4 b 31.92 ± 6.92 24.95 ± 7.84 25.78 ± 6.13 F(1,101) = 14.78 0.000
Stroop Time 5 b 36.28 ± 8.07 28.29 ± 9.48 29.96 ± 8.40 F(1,101) = 11.94 0.000
Stroop Errors 5 b 2.95 ± 2.86 2.36 ± 2.20 3.59 ± 3.25 F(3,35) = 2.90 0.05
5 dots total score a 26.08 ± 6.84 30.16 ± 9.29 24.88 ± 7.81 F(5,85) = 3.24 0.01
5 dots Unique designs a 22.57 ± 6.71 27.45 ± 8.44 21.33 ± 7.18 F(4,101) = 3.49 0.01
5 dots Repetitions b 3.66 ± 4.11 2.79 ± 2.74 3.7 ± 3.2 F(5,85) = 3.24 0.01
TAM interference b 0.8 ± 2.01 1.6 ± 2.61 0.53 ± 1.5 F(4,101) = 3.49 0.01
TAM repetitions b 0.38 ± 0.8 1.18 ± 1.53 0.43 ± 1.29 F(3,38) = 6.66 0.001
TAM words a 33.25 ± 12.59 36.28 ± 16.6 33.85 ± 15.45 F(7,101) = 2.07 0.05
TAM total score a 40 ± 11.78 42.32 ± 16.59 41.13 ± 14.73 F(13,166) = 1.76 0.05
SDMT a 27.04 ± 10.02 32.8 ± 10.88 26.89 ± 10.11 F(4,42) = 5.64 0.001
a. Higher scores indicate better function.
b. higher scores indicate poorer function
CTMT: color trail making test
TAM: TAM verbal flexibility test.
SDMT: symbol digit modalities testBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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ble for reception of stimuli, reduction of irrelevant stim-
uli, sending relevant information to frontal lobe to start to
achieve [7]. Moreover, the results of this test behaviorally
confirmed that patients may have significant impairments
in their abilities to; track any task to the end, arrange
events, maintain attention and resist irrelevant stimuli.
This finding is one of the important factors behind failure
of patients to maintain abstinence, marriage, study or
work.
The results of Stroop test indicated that the differences
increased gradually with the different applications of the
test and reach its maximum in the fourth and fifth appli-
cation where p value was highly significant (0.001). These
results confirmed that the patients had impaired selective
attention, concept formation, correction of errors, set
shifting, behavioral control and modifications according
to stimuli, inhibition of irrelevant responses, self-regula-
tion capability and cognitive flexibility more than the
control group. This may explain the inability of some
patients to shift rapidly and adequately from one behav-
ior to another. Although they know the dangerousness of
their behaviors, they cannot control or change them and
persist on the same style [17,18]. Impaired performance
on Stroop test reflects impaired activation of different
brain areas including the anterior cingulate cortex, dorso-
lateral prefrontal cortex, parietal lobule, insula, and stria-
tum [19]. This deficit may contribute to the impulsivity
seen in patients with substance use disorders especially in
response to substance related cues. Also, it may explain
the frequent relapses of patients [20].
The results of five dots test indicated that the patients had
significant impairment of figural fluency, innovation abil-
ity and cognitive flexibility more than the control group.
The results of this test reflect impairment of frontal lobe
functions and may contribute to the ritualistic stereotyped
behaviors found in addicts [21].
Not only the figural fluency but also word fluency was sig-
nificantly impaired in patients as revealed by TAM verbal
flexibility test. Impairment of TAM test indicates dysfunc-
tion of the left frontal lobe and may contribute to dis-
turbed use of language by patients. That's why some
patients with chronic substance use tend to be socially iso-
lated and cannot make new friends as they cannot com-
municate effectively through language [22].
The speed of mental processing and the ability of patients
to fix and detect errors and learn from them were signifi-
cantly impaired as indicated from symbol digit modalities
test (SDMT). That's why some patients continued to use
the substance whatever the consequences and suffered
from several relapses due to the same mistakes in addition
Table 7: Differences between patients according to duration of use
Duration of substance use
Tests used 1-5 Years
mean ± SD
6-10 Years
mean ± SD
11-15 Years
mean ± SD
>15 Years
mean ± SD
F value P value
CTMT Time 1 b 70.68 ± 32.55 71.92 ± 25.81 75.60 ± 19.73 85.39 ± 22.61 F(3,101) = 2.74 0.05
CTMT Color errors 1 b 1.11 ± 1.41 0.45 ± 0.96 0.31 ± 0.86 0.84 ± 1.19 F(4,45) = 3.75 0.01
CTMT Time 2 b 115.63 ± 34.03 119.04 ± 29.24 122.49 ± 31.82 133.15 ± 40.95 F(3,80) = 2.83 0.04
Stroop time 4 b 25.38 ± 6.36 26.06 ± 6.61 28.87 ± 8.66 29.31 ± 8.28 F(3,101) = 2.68 0.05
Stroop Errors 4 b 2.76 ± 2.37 2.50 ± 2.00 3.29 ± 1.78 3.73 ± 2.46 F(3,50) = 2.80 0.05
Stroop Time 5 b 29.04 ± 7.77 29.71 ± 7.88 31.93 ± 10.15 34.35 ± 10.41 F(7,80) = 2.87 0.01
5 dots total score a 29.51 ± 7.98 28.45 ± 7.89 26.47 ± 2.94 24.64 ± 7.96 F(7,100) = 2.81 0.01
5 dots unique designs a 26.16 ± 7.99 25.28 ± 7.81 22.57 ± 8.76 21.93 ± 6.94 F(3,101) = 2.70 0.05
SDMT a 28.95 ± 11.16 31.85 ± 9.65 30.88 ± 10.58 25.49 ± 10.55 F(4,35) = 3.01 0.032
Benton Rotation errors b 0.32 ± 0.53 0.63 ± 0.87 1.22 ± 1.41 0.87 ± 1.24 F(2,81) = 4.452 0.01
a. Higher scores indicate better function.
b. higher scores indicate poorer function
CTMT: color trail making test
SDMT: symbol digit modality testBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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to slowing of mental processing that impair their abilities
to take the proper decisions at the proper time [23].
Lastly, the patients suffered from significant impairment
of visual-motor coordination, visual perception, visual
memory and visuoconstructive abilities as indicated by
results of Benton visual retention test. Also, this test
reflects impairment of non-dominant temporal and
occipital lobes as well as dorsolateral prefrontal cortex
[24] which is known to modulate problem solving, spatial
planning and corresponds with performance problems
found in the present study. The poor performance of
patient group on Benton test supported the findings of
other studies and suggested a presence of structural dam-
age to the hippocampus out of the toxic effect of the sub-
stances [25].
A lot of other studies observed that there is a strong rela-
tion between abuse of substances and executive functions
especially cognitive flexibility and attention. Most of these
studies focused on alcohol [26-28]. The same results were
also attained in cocaine [29,30], heroin [22] and amphet-
amine users [31]. All these studies indicated a significant
relationship between addiction and deterioration of exec-
utive functions although different tests and study proto-
cols were used. However, the results in the current study
are opposing to results of Rounsavillae et al study [32]
who reported that neuropsychological functions in a sam-
ple of opiate users were better than the control groups.
However, in this study the control group was mainly a
group of epileptic patients. In Qassem et al [22], similar
results were found as regard presence of cognitive dys-
functions in a group of heroin users but in this study they
used Luria Nebraska battery and addiction severity index
not only duration of use and number of hospitalization as
in the current study.
Some studies found that the impairment of cognitive
functions is related to the amount and concentration of
the substance especially alcohol [33,34]. It was difficult in
the current study to include such information as alcohol
is prohibited legally and the available alcohol in this
region is poorly synthesized and has unknown concentra-
tion. Also, the amphetamine available is poorly synthe-
sized with a lot of adulterations and differences in
concentration of the active material within the tablets
[35]. The same was also true as regard heroin as many
patients don't suffer from withdrawal symptoms due to
substance adulteration and the dose doesn't indicate accu-
rately the concentration of substance [36].
Table 8: Differences between patients according to number of hospitalizations: color trail making (CTMT), Stroop and five dots tests
Number of hospitalizations (n)
Tests used 1 (44)
mean ± SD
2 (41)
mean ± SD
3 (38)
mean ± SD
≥ 4 (31)
mean ± SD
F value P value
CTMT Time 1 b 67.40 ± 15.80 68.96 ± 19.14 76.28 ± 21.12 99.59 ± 37.42 F(1,98) = 13.413 0.000
CTMT Color errors 1 b 0.50 ± 0.98 0.39 ± 0.86 0.68 ± 1.16 1.39 ± 1.48 F(4,50) = 5.457 0.001
CTMT Time 2 b 103.52 ± 23.34 114.82 ± 30.57 123.74 ± 29.48 150.55 ± 42.84 F(1,45) = 14.309 0.000
CTMT number errors 2b 0.32 ± 0.80 0.15 ± 0.57 0.45 ± 1.16 1.16 ± 1.77 F(4,48) = 5.465 0.001
CTMT Color errors 2 b 0.48 ± 1.11 0.68 ± 1.46 0.83 ± 1.15 1.35 ± 1.60 F(7,76) = 2.861 0.01
Stroop Time 1 b 10.40 ± 2.21 11.65 ± 1.90 12.08 ± 2.31 15.13 ± 6.06 F(1,265) = 12.662 0.001
Stroop Errors 1 b 0.07 ± 0.33 0.05 ± 0.22 0.08 ± 0.36 0.33 ± 0.83 F(1,77) = 2.706 0.05
Stroop Time 5 b 26.31 ± 7.87 29.42 ± 7.53 31.87 ± 8.04 40.49 ± 8.31 F(1,10) = 20.611 0.001
Stroop Errors 5 b 2.02 ± 2.22 2.87 ± 3.22 3.39 ± 2.54 3.86 ± 2.96 F(1,265) = 12.662 0.001
Total score 5 dots a 31.48 ± 7.73 26.37 ± 8.51 25.76 ± 7.26 23.90 ± 8.31 F(3,39) = 6.587 0.001
5 dots unique designs a 27.93 ± 7.81 23.68 ± 7.64 22.26 ± 7.09 20.71 ± 7.57 F(3,37) = 6.638 0.001
n. number of patients
a. Higher scores indicate better function.
b. higher scores indicate poorer function
CTMT: color trail making testBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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In Table 6 by comparing the three subgroups of patients,
it was found that the alcoholic group was much worse
than amphetamine and lastly heroin group on most of
aspects. Although, the neuropsychological dysfunctions
associated with alcohol are well studied and documented
through a lot of studies [15,27,37], the studies that
directly compare the neuropsychological effects of other
substances with each other are sparse. Similar to the cur-
rent study alcoholics were much worse in Robinson et al
study [38] but the comparison subjects were cocaine
addicts. Also, in another study alcoholics were much
worse than heroin users [39]. Some other studies focused
more on comparisons of single substance users versus
polydrug users as in Bulla et al study [29]and Rosselli and
Ardilla study [30] in which they found that the concomi-
tant use of cocaine plus alcohol or other substances have
additive negative effects on the brain as compared to the
use of only one substance. In Lawton et al study [16],
users of stimulants were compared to users of both alco-
hol and stimulants and it was found that both groups has
negative neuropsychological impacts with more impair-
ments in heroin plus amphetamine group. It looks sound
that use of more than one substance has more negative
additive effect on the cognitive functions that's why the
current study didn't consider including a group of
polysubstance users as a priority.
It is clear that Benton test didn't differentiate between
users of different substances although it differentiates
between patient and control groups. That's because the
task in Benton test primarily depends on attention and it
seems that all substances impact attention negatively.
Following the alcohol group, it was the amphetamine
group that showed more negative impacts on different
aspects of cognitive functions and this was in accordance
with some other studies [29,38,40]. However, in most of
these studies, the subjects were cocaine users. Both
amphetamine and cocaine have nearly similar effects on
the brain. One reason for this significant competition of
amphetamine with the alcohol is the findings from a
Saudi study [35] in which the structure of the available
amphetamine in Saudia Arabia revealed adulteration with
a lot of more dangerous substances like ephedrine, arsenic
and mercury.
The current study chose the duration of use and number
of hospitalizations as indicators for severity of substance
Table 9: Differences between patients according to number of hospitalizations: Tam verbal flexibility, symbol digit modalities (SDMT) 
and Benton visual retention tests
Number of hospitalizations (n)
Tests Used 1 (44)
mean ± SD
2 (41)
mean ± SD
3 (38)
mean ± SD
≥ 4
(31)
mean ± SD
F value P value
TAM correct words a 43.39 ± 16.02 34.73 ± 12.21 29.42 ± 11.55 25.27 ± 11.34 F(1,28) = 13.682 0.001
TAM score a 49.50 ± 16.40 42.46 ± 12.74 36.76 ± 10.63 33.17 ± 10.92 F(1,121) = 11.321 0.001
SDMT a 31.05 ± 8.69 30.56 ± 10.97 29.71 ± 11.59 23.61 ± 10.38 F(4,61) = 3.693 0.01
Benton Errors 1 b 4.84 ± 2.11 5.15 ± 2.89 5.74 ± 2.63 6.55 ± 2.88 F(6,132) = 2.927 0.01
Benton Distortions 1 b 2.93 ± 1.76 2.93 ± 2.04 3.45 ± 2.13 4.10 ± 2.10 F(3,118) = 2.682 0.05
Benton Rotation errors 1 b 0.48 ± 0.70 0.83 ± 0.95 1.08 ± 1.22 0.87 ± 0.99 F(3,74) = 2.741 0.05
Benton responses 2 a 6.55 ± 2.24 6.59 ± 2.16 6.08 ± 2.21 5.19 ± 2.33 F(7,76) = 2.898 0.01
Benton responses3 a 6.48 ± 1.97 6.37 ± 1.61 7.27 ± 1.84 5.65 ± 1.87 F(5,76) = 4.535 0.001
Benton errors 3 b 3.50 ± 1.94 3.66 ± 1.62 2.71 ± 1.81 4.29 ± 1.87 F(3,101) = 4.475 0.005
Benton Distortions 3 b 2.80 ± 2.15 3.24 ± 2.05 2.24 ± 2.16 4.00 ± 1.95 F(3,143) = 4.388 0.005
n. number of patients
a. Higher scores indicate better function.
b. higher scores indicate poorer function
TAM: TAM verbal flexibility test.
SDMT: symbol digit modality testBehavioral and Brain Functions 2009, 5:48 http://www.behavioralandbrainfunctions.com/content/5/1/48
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use problem. All the results of the comparison of different
durations of use by different tests revealed that the
increase in duration of use is always associated with more
deterioration of cognitive dysfunctions. This finding was
in accordance with Becker et al study [33] in which alco-
holic patients developed presenile deterioration of cogni-
tive functions.
Interestingly, impairments were found and different from
control group even in the group of shortest duration of
dependency (1-5 y). It seems that the different substances
have relatively rapid neurotoxic effects, including altera-
tions in grey and white matter, structure and function of
the hippocampus, amygdala, nucleus accumbens, ante-
rior cingulate cortex, orbito-frontal cortex, and perturba-
tions in neurotransmitter responses and metabolism
throughout the mesocorticolimbic system [41,42].
Also the increase in number of hospitalizations was asso-
ciated significantly with more cognitive deficits. This find-
ing was the same on all neuropsychological tests used.
These results are suspected as the number of hospitaliza-
tions is directly related to severity of addiction, number of
relapses, duration of use, and impairment in cognitive
dysfunctions.
Impairment of cognitive functions of patients may be an
important factor affecting the outcome of treatment espe-
cially that the main treatment in substance abuse is cogni-
tive behavioral therapy. Those patients need different
treatment programs to improve their attention and cogni-
tive flexibility. There is a need for rethink the way in which
substance users are assessed at the start of any treatment
program as they need assessment for their cognitive func-
tions through the different neuropsychological batteries.
Also, psychiatrists should consider the different effects of
different substances on cognitive functions of patients.
Moreover, the duration of any treatment program should
be tailored to patients needs as patients with cognitive
impairment need longer durations in a protective envi-
ronment.
In future studies correlation of neuropsychological testing
results with functional brain imaging is highly recom-
mended. Moreover, to know the exact relation of this cog-
nitive dysfunction associated with substances and
whether it is a trait, state or scar marker, it is beneficial to
do longitudinal studies and to take patients in different
stages of addiction and abstinence.
Limitations
A common problem in most of substance use studies is
the difficulty to find patients with single substance of
abuse that's why the recruitment of cases in the current
study took 18 months. Also, matching of patients and
control then matching of patient subgroups was a difficult
task and many patients were excluded to allow this match-
ing. Another limitation is that patients were tested at few
days post-detoxification, limiting the ability to generalize
to longer periods of abstinence. It is important to note
that most studies of substance use disorders suggest that
drug use affects cognitive function even though baseline
measures are not available but some level of impairment
may antedate and perhaps contribute to the development
of drug abuse particularly in light of evidence that cogni-
tive dysfunction is more prevalent in adolescents who are
at high risk for substance abuse [4,43].
Conclusion
The current study suggests that the functions of specific
brain regions underlying cognitive control are signifi-
cantly impaired in patients of drug addiction. This impair-
ment was identified in groups based on primary drug of
abuse, duration of addiction and number of hospitaliza-
tions. Cognitive dysfunctions may contribute to most of
behavioral disturbances found in patients with substance
use disorders and need much attention during tailoring of
treatment programs for patients.
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